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The purpose of this study was to characterize mechanisms of plasmid-mediated
antimicrobial resistance in Shigella boydii. S. boydii strain 2246 with resistance
to ciprofloxacin, ceftriaxone and azithromycin was isolated from a human case of
watery diarrhea in a Chinese public hospital. Resistance in strain 2246 to ceftriaxone
and azithromycin was attributable to the presence of blaCTX−M−14, and erm(B) and
mph(A), respectively, which were co-located on a multidrug-resistant (MDR) plasmid
p2246-CTXM. p2246-CTXM represented a novel IncFII-type MDR plasmid with a very
complex chimera structure. Its master backbone was genetically closely related to the
R100 plasmid, but p2246-CTXM had evolved to integrate additional R100-unrelated
backbone regions as well as massive exogenous mobile elements that carried multiple
resistance determinants. In p2246-CTXM, erm(B) together with its leading peptide gene
erm(C), mph(A) together with its regulatory genes mrx and mphR(A), and blaCTX−M−14
were captured by three different mobile elements Tn6295, the IS26-mph(A)-mrx-
mphR(A)-IS6100 unit, and a truncated ISEcp1-blaCTX−M -IS−14 903D-iroN transposition
unit, respectively, all of which were harbored in a large Tn3-family transposon Tn6285.
p2246-CTXM still carried additional resistance determinants mer (mercury resistance),
aacA4 (aminoglycoside resistance), cmlA1 (chloramphenicol resistance), and qacED1
(quaternary ammonium compound resistance). This is the first report of identifying
a clinical S. boydii strain simultaneously resistant to ciprofloxacin, ceftriaxone, and
azithromycin, and determining the complete sequence of a resistance plasmid from
S. boydii.
Keywords: Shigella boydii, p2246-CTXM, blaCTX−M−14, erm(B), mph(A)
INTRODUCTION
Shigellosis remains a common gastrointestinal disease in both developing and industrialized
countries. Shigella, the causative agent of shigellosis, can be serologically grouped into four species
S. flexneri, S. sonnei, S. boydii, and S. dysenteriae. Being together responsible for about 90% of
shigellosis, S. flexneri and S. sonnei are the most prevalent species in developing and developed
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countries, respectively, but a shift in the dominant species from
S. flexneri to S. sonnei has occurred in countries with recent
rapid improvement of socioeconomic conditions (Livio et al.,
2014; Lima et al., 2015). S. boydii accounts for around 10%
of the Shigella isolates found in the samples from the Indian
subcontinent that is considered as S. boydii endemic areas, but
this pathogen remains very rare (less than 1% of the total Shigella
isolates) in other areas (Livio et al., 2014; Lima et al., 2015).
Multidrug-resistant (MDR) isolates of S. flexneri and S. sonnei
have been reported worldwide. The previously efficacious old-
generation antimicrobials such as ampicillin, chloramphenicol,
tetracycline, and sulphonamides have become ineffective in the
treatment of shigellosis (Niyogi, 2007; Zhang W. et al., 2011).
The situation is getting worse due to the increasing emergence
of resistance in Shigella to ciprofloxacin, ceftriaxone, and
azithromycin (Klontz and Singh, 2015). The WHO recommends
ciprofloxacin as the first choice for the treatment of multidrug-
resistant shigellosis, while ceftriaxone and azithromycin can be
used as the alternatives for both adults and children and they
are preferred among young children because of the concerns
regarding the adverse effects of ciprofloxacin in young children
(Christopher et al., 2010).
This study describes not only the first reported S. boydii isolate
with resistance to ciprofloxacin, ceftriaxone and azithromycin
but also the first fully sequenced resistance plasmid from
S. boydii. This plasmid, designated p2246-CTXM, is a novel
MDR plasmid of the IncFII incompatibility group, and it carries
several different resistance determinants especially including
blaCTX−M−14 (cephalosporin resistance), and erm(B) and mph(A)
(macrolide resistance).
MATERIALS AND METHODS
Bacterial Identification
The use of human specimens and all related experimental
protocols were approved by the Committee on Human Research
of indicated institutions and carried out in accordance with
the approved guidelines. S. boydii species was identified by
slide agglutination using monovalent antisera of Denka Seiken
(Tokyo, Japan) and monoclonal antibody reagents of Reagensia
AB (Solna, Sweden). The agglutination was sensitively scored
according to the following scale: +++, 100% agglutination of
the cells; ++, >50% agglutination; +, <50% agglutination; −,
no agglutination detected.
Detection of Resistance Genes
The major horizontally acquired quinolone-resistance genes,
extended-spectrum β-lactamase (ESBL) genes, and macrolide-
resistance genes were screened by PCR (Supplementary Table
S1), followed by amplicon sequencing on ABI 3730 Sequencer
(LifeTechnologies, Carlsbad, CA, USA).
Plasmid Transfer, Sequencing and
Annotation
Plasmid conjugal transfer were performed with Escherichia coli
EC600 (LacZ−, NalR, and RifR) being used as recipient for
selection of blaCTX−M-positive transconjugants (Chen et al.,
2015). Plasmid DNA was isolated from E. coli transconjugant
using Qiagen large construct kit (Qiagen, Hilden, Germany), and
sequenced by whole-genome shotgun strategy in combination
with Illumina HiSeq 2500 (Illumina, San Diego, CA, USA)
sequencing technology. The contigs were assembled with Velvet
version 1.2, and the gaps were filled through combinatorial
PCR and Sanger sequencing on ABI 3730 Sequencer. The
genes were predicted with GeneMarkSTM and RAST and further
annotated by BLASTP and BLASTN against UniProt and NR
databases. Annotation of mobile elements was based on the
databases ISfinder, INTEGRALL, Tn Number Registry, and ISCR
Elements. Gene organization diagrams were drawn with Inkscape
version 0.48.
Phenotypic Analyses
Enzymatic activity of ESBL was determined by the combined
disk test as recommended by Clinical and Laboratory
Standards Institute (CLSI; CLSI, 2015). Bacterial antimicrobial
susceptibility was tested by ETEST (BioMérieux, Hazelwood,
MO, USA) for erythromycin and azithromycin and by VITEK
2 (BioMérieux Vitek, Hazelwood, MO, USA) for all the other
drugs (Table 1), and interpreted as per CLSI guidelines (CLSI,
2015).
RNA Isolation and Primer Extension
Assay
Bacteria were cultured overnight in Mueller-Hinton broth
with addition of indicated antibiotics. Total RNAs were
extracted from harvested bacterial cells using TRIzol Reagent
TABLE 1 | Antimicrobial drug susceptibility profiles.
Category Antibiotics MIC (mg/L)/antimicrobial susceptibility
2246 2246-CTXM
-EC600
EC600
Penicillins Piperacillin ≥128R ≥128R ≤4S
Piperacillin/
tazobactam
8S ≤ 4S ≤4S
Cephalosporins Cefazolin ≥64R ≥64R ≤4S
Cefuroxime ≥64R ≥64R 16I
Ceftriaxone ≥64R ≥64R ≤1S
Macrolides Erythromycina ≥256 ≥256 12
Azithromycina ≥256 ≥256 2
Fluoroquinolones Ciprofloxacin ≥4R ≤0.25S ≤0.25S
Levofloxacin ≥8R 1S 0.5S
Carbapenems Imipenem ≤1S ≤1S ≤1S
Meropenem ≤0.25S ≤0.25S ≤0.25S
Aminoglycosides Amikacin ≤2S ≤2S ≤2S
Gentamicin ≤1S ≤1S ≤1S
Sulfanilamides Trimethoprim/
sulfamethoxazole
≤20S ≤20S ≤20S
S = sensitive; R = resistant. a’R’ and ’S’ cannot by judged due to because
erythromycin an azithromycin susceptibility testing guidelines and interpretive
criteria are currently lacking for Shigella.
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(Life Technologies). The oligonucleotide primers 5′-GCA
CTCTCTTTGTCACCATCTC-3′, 5′-CTACATAACGCATTTGA
TAACGC-3′, and 5′-CCATGTCGGGCTGCAAGTGCGTACAG
TTGGG-3′ were designed to be complementary to the RNA
transcripts of blaCTX−M−14, erm(B)L and mph(A), respectively,
and end-labeled with [γ-32P] ATP. About 10 µg of end-labeled
primer were annealed with 3 µg of RNA for the primer extension
assay with a Primer Extension System (Promega) as described
previously (Zhang Y. et al., 2011). The end-labeled primer
was used for sequencing the PCR amplicons generated by the
primer pairs 5′-TTAAGTATCATTGCAGCAAAG-3′/5′-GCA
CTCTCTTTGTCACCATCTC-3′, 5′-AACGCTGAACCCAGCG
GTAAATCGT-3′/5′-TACTCCTGAAGTGATTACATCT-3′, and
5′-ATGGCAAACTGAAACGGAT-3′/5′-CCTCTGGTTCGACC
TTCG-3′ for blaCTX−M−14, erm(B)L, and mph(A), respectively.
DNA sequencing was carried out using the AccuPower & Top
DNA Sequencing Kit (Bioneer). The primer extension products
and sequencing materials were analyzed on an 8 M urea-6%
polyacrylamide gel electrophoresis. Radioactive species were
detected by autoradiography.
Nucleotide Sequence Accession Number
The complete sequence of p2246-CTXM was submitted to
GenBank under accession number KX646543.
RESULTS
Characterization of S. boydii Strain 2246
and Its Drug Susceptibility
In October 2013, a 51-year-old male with watery diarrhea
and liver dysfunction (further diagnosed as liver cirrhosis)
was admitted to a public hospital in Beijing, China. Bacterial
growth could be observed after culture of fresh stool specimens
of the patient on the Salmonella-Shigella agar. The bacterial
isolate, designated as 2246, was identified as S. boydii using
slide agglutination. Based on the antimicrobial susceptibility
test results, the patient received oral administration with
piperacillin/tazobactam, and his symptoms of diarrhea
progressively disappeared.
As determined by PCR screening for the major plasmid-borne
quinolone-resistance, ESBL, and macrolide-resistance genes,
strain 2246 harbored blaCTX−M−14, erm(B), and mph(A) rather
than any of the other genes tested. These three resistance
markers could be co-transferred from strain 2246 into EC600
through conjugation, generating a transconjugant 2246-CTXM-
EC600. Strains 2246 and 2246-CTXM-EC600 had the ESBL
enzyme activity (Supplementary Figure S1). Both 2246 and
2246-CTXM-EC600 were resistant to piperacillin, cefazolin,
cefuroxime, and ceftriaxone, but remained susceptible to
piperacillin/tazobactam, imipenem and meropenem, gentamicin
and amikacin, and trimethoprim/sulfamethoxazole; 2246
rather than 2246-CTXM-EC600 was resistant to ciprofloxacin
and levofloxacin (Table 1). Notably, both 2246 and 2246-
CTXM-EC600 possessed greatly elevated minimal inhibitory
concentration (MIC) values (≥256 mg/L) against erythromycin
and azithromycin (Table 1).
General Features of p2246-CTXM
High-throughput sequencing analysis using plasmid DNA
sample isolated from 2246-CTXM-EC600 generated the entire
nucleotide sequence of a single plasmid p2246-CTXM (Figure 1)
with a mean coverage of 135. The p2246-CTXM genome was
manifested as an 111,559 bp circular DNA molecular with a mean
G+C content of 51.9% and carried a total of 143 predicted open
reading frames (ORFs).
The modular structure of p2246-CTXM could be divided into
two major regions, namely, a 55-kb plasmid R100 (accession
number AP000342)-derived backbone region with insertion
of three different insertion sequences, and a 56.4-kb mosaic
region composed of several plasmid backbone sequences and
accessory mobile elements of different evolutionary origins. The
R100-derived backbone sequences contained DNA regions for
plasmid replication (repA2, repA6, and repA1 of the IncFII
incompatibility group), maintenance (repA4, tir, pemIK, etc) and
conjugal transfer (tra, trb, yfiABC, etc). One copy of each of IS2,
IS903D and IS1 was inserted into the R100-derived backbone
sequences, disrupting them into four separate portions. The
transposition of IS2, IS903D and IS1 leaved three different direct
repeats (DRs: target site duplication signals of transposition), i.e.,
GTTTA, GCATAAATC, and CGCGACGGG, which flanked the
corresponding inserted elements, respectively. The insertion of
IS2 and IS903D truncated the backbone genes traJ and yfhA,
respectively.
Located at different sites of the backbone of R100 were three
copies of repeat D, around 438 bp in length, two of which were
found in p2246-CTXM. It seemed that the repeat D-mediated
homologous recombination led to the deletion of one copy
of repeat D together with a 14-kb region containing plasmid
maintenance genes ssb, ydeAB, ydgA, yefA, psiBA, sok, mok, hok,
and yehA.
The Mosaic Region of p2246-CTXM
The 56.4-kb mosaic region of p2246-CTXM (Figure 2) could be
divided into two parts and the first part was composed of an
intact IS1 element, and a novel transposon designated Tn6285
bordered by 40 bp imperfect terminal inverted repeats (IRs) at
both ends.
Tn21, as observed in plasmid R100, was a Tn3-family
unit transposon which was sequentially organized as the core
transposition module tnpA (transposase)-tnpR (resolvase), tnpM,
the Tn402-related class 1 integron In2 that was delimited by 25 bp
IRs [inverted repeat initial (IRi) plus inverted repeat terminal
(IRi)] associated 5 bp DRs, urf2, and the mer gene cluster (Liebert
et al., 1999).Tn21 was bordered by 38 bp IRs [inverted repeat left
(IRL) plus inverted repeat right (IRR)] at both ends. It was though
that the insertion of In2 into Tn21 disrupted a presumed ancestral
urf2M gene into two separate ones urf2 and tnpM.
A Tn21 remnant, which comprised two separate fractions
IRLTn21-mer-urf2-DRIn2- IRiIn2-1tniA and IRtIn2-DRIn2-tnpM,
was found in Tn6285 (Figure 2). Separation of these two
fraction was likely resulted from the insertion of two consecutive
resistance elements Tn6295 (name given in this study) and IS26-
mph(A)-mrx-mphR(A)-IS6100, which were found at two different
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FIGURE 1 | Schematic map of p2246-CTXM. Genes are denoted by arrows and colored based on gene function classification. The innermost two circles present
the GC-Skew [(G−C)/(G+C)] and the GC contents. Shown also are the backbone and the accessory modules, respectively.
locations in pETN48 (accession number FQ482074), a CTX-M-
14-encoding plasmid of the FII-FIB replicon type and originating
from an E. coli O102-ST405 strain (Billard-Pomares et al., 2011).
Tn6295 (Figure 2) was a composite transposon, which had
two flanking copies of IS26 oriented in the same direction
and was further delimited by DRs of GGA at both ends;
moreover, an ISCR14 element and a macrolide-resistance
operon erm(B)L (leading peptide)-erm(B) (methylase) were
found in Tn6295.The IS26-mph(A)-mrx- mphR(A)-IS6100 unit
was known as a mobile element, which harbored another
macrolide-resistance operon mph(A)-mrx-mphR(A) encoding
a phosphotransferase, a positive regulator and a negative
transcription factor, respectively (Partridge, 2011). Notably,
the upstream IS26 copy of Tn6295 and the counterpart of
the IS26-mph-IS6100 unit overlapped each other in Tn6285,
indicating that the connection of Tn6295 with IS26-mph(A)-mrx-
mphR(A)-IS6100 was mediated by homologous recombination in
IS26.
Upstream of tnpM in Tn6285 was a 9.5 kb region, which was
composed in order of 1In153, a Tn1722 remnant, a truncated
version of the ISEcp1-blaCTX−M−14-based transposition unit
(IB14TU), and IS26 (Figure 2). This region was highly similar
to that from nucleotide position 80171–70422 of pETN48. The
tnpM gene was flanked by IRtIn2 and IRiIn153, and it appeared
that the homologous recombination mediated by these two 25 bp
IRs characteristic of class 1 integrons led to the inversion of tnpM
in Tn6285 relative to Tn21. The1In153 in Tn6285 contained two
resistance gene cassettes aacA4:attCaacA4 and cmlA1:attCcmlA1
and this class 1 integron had undergone the truncation of sulI
and the loss of IRt in the 3′-conserved segment. Tn1722 was
a Tn3-family cryptic transposon initially identified in E. coli,
with a modular structure IRLTn1722-tnpA-tnpR-mcp (methyl-
accepting chemotaxis protein)-IRRTn1722 (Allmeier et al., 1992).
The Tn1722 remnant in Tn6285 manifested as1mcp-IRRTn1722.
pETN48 carried a prototype IB14TU, bound by 14 bp terminal
IRs, which contained blaCTX−M−14 together with an upstream
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FIGURE 2 | The mosaic region of p2246-CTXM with comparison to similar elements. Genes are denoted by arrows and colored based on gene function
classification. Shading regions denote shared DNA regions of homology (>95% nucleotide similarity).
ISEcp1 and a downstream IS903D followed by 1iroN. Similar
structures of IRLISEcp1-tnpAISEcp1-IRRISEcp1-blaCTX−M-IS903D-
1iroN- IRRISEcp1 were found in various plasmids of global origin
(Zong et al., 2011). Compared with pETN48, Tn6285 harbored
a truncated IB14TU element, which had undergone the loss of
tnpA574to973 (position 574 to 973 of the total 1263 bp coding
region of tnpA in ISEcp1) and1iroN-IRRISEcp1, and the inversion
of tnpA974to1263-IRRISEcp1-blaCTX−M−14-IS903D (Figure 2).
The second part of the 56.4-kb mosaic region contained
four plasmid backbone-derived sequences, designated DBS-1to
DBS-4 in the order that they occur (Figure 2). DBS-1 was a
926 bp region with two annotated genes encoding hypothetical
proteins, which showed 93% sequence similarity to the IncFII-
type plasmid pSE11-1 from E. coli (Oshima et al., 2008). Located
between DBS-1 and DBS-2 was an IS1 element. The 18.7-kb
DBS-2 contained the colicin Ia activity-immunity system cia–cii,
and it was highly similar to a 15-gene region of pSE11-1. Two
separate insertions, i.e., IS26 connected with a Tn5396 remnant,
and a novel insertion sequence designated ISSbo2, occurred
within DBS-2 relative to pSE11-1. Tn5396 was a Tn3-family
cryptic transposon initially identified in the small plasmid pEC22
from E. coli, with a modular structure IRLTn5396-tnpA-tnpR-orf6
-orf7-IRRTn5396 (Elhai et al., 1994), and the 3′-end region1tnpR-
orf6-orf7-IRRTn5396 constituted the Tn5396 remnant observed
in p2246-CTXM. The 3.6-kb DBS-3 was highly similar to a 7-
gene region of the E. coli genome assembly FHI74 (accession
number LM996602), which contained the toxin-antitoxin system
ccdBA, the colicin M immunity-activity system cmi–cma and the
colicin B system cbi–cba. An IS1 element was inserted into DBS-3,
leaving cmi and cba truncated. The 6.4-kb DBS-4 was found in the
IncI1-type plasmid pC271 (accession number LN735561) from
E. coli and contained several plasmid maintenance genes such as
parA, stbAB, and impCAB.
Expression of blaCTX−M−14, erm(B), and
mph(A)
Spacer regions between ISEcp1 and blaCTX−M−55 from different
ISEcp1-blaCTX−M−55 isoforms displayed three different lengths,
namely 45 bp (e.g., blaCTX−M−55p1081−CTXM) (Qu et al., 2014),
48 bp (e.g., blaCTX−M−55p2246−CTXM in this study), and 127 bp
(e.g., blaCTX−M−55JQ343851 and blaCTX−M−3AF550415; Figure 3).
A total of two promoters P1 and P2 were experimentally
identified for blaCTX−M−3AF550415 with a 127 bp spacer and,
moreover, the ISEcp1-provided promoter P1 was stronger and
more important than the intrinsic P2 promoter in the 127 bp
spacer (Ma et al., 2011).
Compared with the 127 bp spacer, the 45 or 48 bp spacer
from blaCTX−M−55p1081−CTXM or blaCTX−M−55p2246−CTXM was a
truncated form due to the loss of an 82 or 79 bp region within
the spacer, respectively (Figure 3). This deletion impaired the -35
element of P2, most likely making the P2 activity undetectable
for blaCTX−M−55p1081−CTXM and blaCTX−M−55p2246−CTXM. In
the present study, the primer extension assay detected a single
transcription start, i.e., nucleotide G located at 116 bp upstream
of blaCTX−M−55 (Figure 4), which corresponded to the P1
promoter shared by blaCTX−M−55p1081−CTXM (Qu et al., 2014)
and blaCTX−M−55p2246−CTXM (Figure 3). In addition, the primer
extension assay showed that the addition of increasing amounts
of ampicillin during cultivation of strains 1081 and 1081-CTXM
EC600 had no effect on the activity of blaCTX−M−55p2246−CTXM
promoter (Figure 4), denoting the constitutive expression of
blaCTX−M−55p2246−CTXM.
The primer extension assay detected a transcription start for
each of erm(B)L and mph(A) from p2246-CTXM, i.e., nucleotide
T located at 52 bp upstream of erm(B)L, and G at 31 bp upstream
of mph(A); in addition, this assay also showed the inducible
expression of erm(B)L and mph(A) upon addition of increasing
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FIGURE 3 | Alignment of blaCTX−M upstream sequences. The 150- to 235-bp upstream sequences together with the start codon of the blaCTX−M genes were
aligned by MAFFT (http://www.ebi.ac.uk/Tools/msa/mafft/). Shown were core promoter regions, −35 and −10 elements, transcription starts, Shine–Dalgarno (SD)
sequences for ribosome recognition, and translation starts.
amounts of amikacin and azithromycin, respectively (Figure 4).
The above results were consistent with the expression patterns
previously characterized for the two macrolide-resistant operons
erm(B)L-erm(B) (Min et al., 2008) and mph(A)-mrx-mphR(A)
(Noguchi et al., 2000).
DISCUSSION
The current emergence and spread of resistance in Shigella
strains to ciprofloxacin, ceftriaxone and azithromycin hinder
the empirical antimicrobial therapy. Antimicrobial resistance
patterns and mechanisms are overwhelmingly documented for
S. flexneri and S. sonnei, and very little is currently known
about S. boydii due to small number of available strains. This
work describes a clinical S. boydii strain 2246 simultaneously
resistant to ciprofloxacin, ceftriaxone, and azithromycin. As
shown by PCR detection, strain 2246 contains none of the
known horizontally acquired quinolone-resistance genes (data
not shown). It seems that strain 2246 employs chromosomal-
borne intrinsic mechanism(s) of quinolone resistance. Resistance
in strain 2246 to ceftriaxone and azithromycin is attributable
to the presence of blaCTX−M−14, and erm(B) and mph(A),
respectively, which are co-located on a MDR plasmid p2246-
CTXM.
CTX-M-type ESBLs have the high hydrolytic activity against
cefotaxime and they can be divided now into five major
phylogenetic groups, i.e, the CTX-M-1 group, the CTX-M-2
group, the CTX-M-8 group, the CTX-M-9 group, and the CTX-
M-25 group (D’Andrea et al., 2013). CTX-M enzymes have
showed the rapid increasing circulation in Shigella species in
China during the past decade, and CTX-M-14 (a member of
CTX-M-9 group), and CTX-M-15 and CTX-M-55 (belonging
to the CTX-M-1 group) are listed sequentially as the top three
common types of ESBL in the cefotaxime-resistant S. flexneri or
S. sonnei from China (Zhang W. et al., 2011; Li et al., 2015).
Acquired resistance to macrolides in bacteria mainly result
from three distinct mechanisms of resistance (Phuc Nguyen et al.,
2009): target ribosome site modification by methylases [erm(A),
erm(B), and erm(C)]; macrolide modification by esterases [ere(A)
or ere(B)] or by phosphotransferases [mph(A), mph(B), and
mph(D)]; and presence of eﬄux pumps [mef(A) and msr(A)].
Identification of azithromycin-resistant Shigella strains is rare
and has been documented for only S. flexneri or S. sonnei
from France (Boumghar-Bourtchai et al., 2008), the United
States (Howie et al., 2010; Sjolund Karlsson et al., 2013) and
Canada (Gaudreau et al., 2014), and all these azithromycin-
non-susceptible Shigella isolates harbor the mphA gene. Notably,
the p2246-CTXM plasmid coharbors erm(B) and mph(A), which
account for two different transferable mechanisms of macrolide
resistance.
Up to now, a total of seven virulence or cryptic S. boydii
plasmids pBS512_211, pSB4_227, pBS512_2, pBS512_33,
pBS512_5, pBS512_7, and pSB13 have their complete nucleotide
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FIGURE 4 | Expression of resistance genes. Primer extension assay of the RNA transcript of each of the genes blaCTX−M−14 (A), erm(B)L (B) and mph(A) (C),
was performed for the two strains 2246 and 2246-CTXM-EC600 cultured with addition of increasing amounts of indicated antibiotics. Lanes C, T, A and G represent
Sanger sequencing reactions. Lanes 0, 200, and 400 stand for 0, 200, and 400 mg/L ampicillin (A), respectively. Lanes 0, 5, and 15 represent 0, 5, and 15 mg/L
amikacin (B) or azithromycin (C), respectively. Transcription start of each gene is indicated by arrow with nucleotide, and minus number under arrow indicates
nucleotide position upstream of each gene. Representative data from at least two independent biological replicates are shown.
sequences that ranged from 2 to 211 kb in size. This work
presents the first fully sequenced resistance plasmid from
S. boydii. p2246-CTXM represents a novel IncFII-type MDR
plasmid with a very complex chimera structure. Its master
backbone is genetically closely related to the R100 plasmid, but
p2246-CTXM has evolved to integrate additional R100-unrelated
backbone regions as well as massive exogenous mobile elements
that carry multiple resistance determinants.
In p2246-CTXM, erm(B) together with its leading peptide
gene erm(C), mph(A) together with its regulatory genes
mrx and mphR(A), and blaCTX−M−14 are captured by three
different transposable units Tn6295, IS26-mph(A)-mrx-
mphR(A)-IS6100, and IB14TU, respectively, all of which
are harbored in a large transposon Tn6285. p2246-CTXM
still carries several additional resistance determinants mer
(mercury resistance), aacA4 (aminoglycoside resistance),
cmlA1 (chloramphenicol resistance), and qacED1 (quaternary
ammonium compound resistance). The coexistence of multiple
resistance genes on the same transmissible plasmid might
contribute to bacterial dissemination and persistence in
various hosts and environments with different antimicrobial
selections. Future surveillance and epidemiological studies
are needed to evaluate the prevalence of p2246-CTXM-
like plasmids among Shigella isolates in China and other
countries.
AUTHOR CONTRIBUTIONS
DsZ, and YF designed experiments. LW, LL, DL, and ZY
performed experiments. DsZ, and LW analyzed data. JF, DfZ, HF,
YQ, WC, RY, and JW contributed reagents, materials and analysis
tools. DsZ, YF, and LW, wrote this manuscript.
ACKNOWLEDGMENTS
This work is funded by the National Natural Science Foundation
of China (81501779) and the National High-Tech Research and
Development Program of China (2014AA021402).
Frontiers in Microbiology | www.frontiersin.org 7 October 2016 | Volume 7 | Article 1579
fmicb-07-01579 October 4, 2016 Time: 16:25 # 8
Wang et al. Plasmid p2246-CTXM from S. boydii
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: http://journal.frontiersin.org/article/10.3389/fmicb.2016.01579
FIGURE S1 | The combined disk test. Experiments are conducted with three
plates inoculated with three independent bacterial cultures for each strain, and
only a representative figure is shown herein. CTX: 30 µg of cefotaxime; CAZ:
30 µg of ceftazidime; CTX+CA: 30 µg of cefotaxime plus 10 µg of clavulanic acid;
CAZ+CA: 30 µg of ceftazidime plus 10 µg of clavulanic acid. Clavulanic acid is a
member of the β-lactam family of antibiotics with little or no intrinsic antibacterial
activity of its own; instead, it is used to enhance the activity of antibiotics by
blocking bacterial β-lactamases as a competitive inhibitor of β-lactamases.
A ≥ 5 mm increased in the zone diameter for either cefotaxime (30 µg) or
ceftazidime (30 µg) tested in combination with clavulanic acid (10 µg) versus its
zone when tested alone indicates the ESBL activity in the indicated strain. The
results showed the ESBL activity in strains 2246 and 2246-CTXM-EC600.
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